| 序号 | CAS | 产品名称 | 规格 | 包装 |
参考价格 |
| 1 | 119006-77-8 | Flutrimazole |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 2 | 155633-54-8 | Drometrizole trisiloxane(Mexoryl XL) |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 3 | 1619903-54-6 | LY-2857785 |
≥98% | | 询价 |
| 4 | 1824637-41-3 | VY-3-135 |
≥98% | | 询价 |
| 5 | 1374745-52-4 | Telotristat besilate |
≥98% | | 询价 |
| 6 | 763-32-6 | 3-Methyl-3-buten-1-ol |
≥98% | | 询价 |
| 7 | 56391-57-2 | Netilmicin Sulfate(SCH-20569) |
≥98% | | 询价 |
| 8 | 162881-26-7 | Phenylbis(2,4,6-trimethylbenzoyl)phosphine oxide |
≥98% | | 询价 |
| 9 | 206133-42-8 | Fmoc-Phe-Lys(Boc)-PAB |
≥98% | | 询价 |
| 10 | 2095886-80-7 | NV-5138 |
≥98% | | 询价 |
| 11 | 95906-11-9 | Tris(2,4-di-tert-butylphenyl)phosphate |
≥98% | | 询价 |
| 12 | 1394011-91-6 | UC2288 |
≥98% | | 询价 |
| 13 | 1432969-86-2 | Val-Lys(Boc)-PAB |
≥98% | | 询价 |
| 14 | 2056122-11-1 | HPK1-IN-2 |
≥98% | | 询价 |
| 15 | 1197824-15-9 | EN4 |
≥98% | | 询价 |
| 16 | 2088410-46-0 | GSK620 |
≥98% | | 询价 |
| 17 | 58186-27-9 | Idebenone(CV-2619) |
≥98% | | 询价 |
| 18 | 684236-01-9 | CAY10698 |
≥98% | | 询价 |
| 19 | 2409963-83-1 | Lysyl oxidase inhbitor 1 |
≥98% | | 询价 |
| 20 | 2225836-30-4 | ACH-000143 |
≥98% | | 询价 |
| 21 | 1858206-76-4 | BTK inhibitor 17 |
≥98% | | 询价 |
| 22 | 28469-92-3 | 2,6-Dichlorostyrene |
≥98% | | 询价 |
| 23 | 1334953-95-5 | Elamipretide Acetate |
≥98% | | 询价 |
| 24 | 1338574-93-8 | WWL-154 |
≥98% | | 询价 |
| 25 | 18080-67-6 | Conoidin A |
≥98% | | 询价 |
| 26 | 849669-54-1 | NSC-741764 |
≥98% | | 询价 |
| 27 | 371924-24-2 | MCU-i4 |
≥98% | | 询价 |
| 28 | 1771756-32-1 | NI-1-Br |
≥98% | | 询价 |
| 29 | 17598-82-2 | L-Tagatose |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 30 | 105857-23-6 | Alteplase |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 31 | 93413-46-8 | R-Venlafaxine |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 32 | 93413-44-6 | S-Venlafaxine |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 33 | 2095484-82-3 | (R)-eIF4A3-IN-2 |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 34 | 256649-36-2 | CRA-2059 |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 35 | | TPX-0046 |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 36 | 114014-15-2 | Z-Phe-Tyr(tBu)-diazomethylketone |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 37 | 1793080-72-4 | VX-150 |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 38 | 146714-97-8 | WAY 100635 HCl |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 39 | 2376255-48-8 | Ac-FLTD-CMK |
≥98% | | 询价 |
| 40 | 2753-45-9 | Mebeverine hydrochloride |
≥98% | | 询价 |
| 41 | 188589-66-4 | Cl-4AS-1 |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 42 | 6018-41-3 | Methyl Coumalate |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 43 | 1421936-85-7 | Iclepertin(BI-425809) |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 44 | 1093851-61-6 | Oseltamivir-d3 |
≥98% | | 询价 |
| 45 | 2460249-19-6 | PF-07104091 |
≥98% | | 询价 |
| 46 | 1948229-21-7 | Eliapixant |
≥98% | | 询价 |
| 47 | 890056-27-6 | Custirsen |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 48 | 143183-63-5 | Adhyperforin |
≥98% | | 询价 |
| 49 | 849217-68-1 | Cabozantinib(XL184 BMS907351 Cometriq) |
≥98% | | 询价 |
| 50 | | Osteoblast Activating Peptide(human) |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 51 | 600171-70-8 | Orphan GPCR SP9155 Agonist P550(mouse) |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 52 | 532932-99-3 | (Ala11,D-Leu15)-Orexin B(human) |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 53 | | Hypocretin(70-98)(human) |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 54 | 1815618-11-1 | Biotin-Obestatin(human) |
≥98% | | 询价 |
| 55 | 1081110-72-6 | Obestatin(human) |
≥98% | | 询价 |
| 56 | | (Phe1-(R)-Gly2)-Nociceptin(1-13)amide |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 57 | | Neurotrophic Factor for Retinal Cholinergic Neurons |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 58 | | Brain Injury Derived Neurotrophic Peptide |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 59 | | Neuronostatin-19(mouse,rat) |
≥98% | 50mg, 100mg, 250mg | 询价 |
| 60 | 1872435-06-7 | Neuronostatin-19(human,canine,porcine) |
≥98% | | 询价 |
m.cnreagent.com